Free Trial

Stryker Q4 2022 Earnings Report

Stryker logo
$364.60 +7.46 (+2.09%)
(As of 12/20/2024 05:30 PM ET)

Stryker EPS Results

Actual EPS
$3.00
Consensus EPS
$2.84
Beat/Miss
Beat by +$0.16
One Year Ago EPS
$2.71

Stryker Revenue Results

Actual Revenue
$5.20 billion
Expected Revenue
$4.97 billion
Beat/Miss
Beat by +$232.45 million
YoY Revenue Growth
+10.70%

Stryker Announcement Details

Quarter
Q4 2022
Time
After Market Closes

Conference Call Resources

Conference Call Audio

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

Stryker Earnings Headlines

TD Cowen Sticks to Its Buy Rating for Stryker (SYK)
RBC Capital Sticks to Their Buy Rating for Stryker (SYK)
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Reasons to Invest in Stryker Corp. (SYK)
Reasons to Invest in Stryker Corp. (SYK)
See More Stryker Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Stryker? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Stryker and other key companies, straight to your email.

About Stryker

Stryker (NYSE:SYK) operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

View Stryker Profile

More Earnings Resources from MarketBeat

Upcoming Earnings